Home » Topics » BioWorld Science

BioWorld Science
RSS

LISCure and Scripps collaborate on bacteria-mediated immuno-oncology candidates for cancer

Feb. 4, 2022

Study links mycobiome, IL-33, tumor growth in pancreatic cancer

Feb. 4, 2022

Novel preclinical models of invasive papillary cholangiocarcinoma

Feb. 4, 2022

New plasma kallikrein inhibitors identified at Merck Sharp & Dohme

Feb. 4, 2022

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

Feb. 4, 2022

Enanta Pharmaceuticals presents compounds for influenza, RSV infections

Feb. 4, 2022

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Feb. 4, 2022

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

Feb. 4, 2022

Researchers present preclinical model of ALS

Feb. 4, 2022

Meta-analysis reveals candidate variants associated with brain traits

Feb. 4, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...